A retrospective study of ensartinib-treated ALK-positive locally advanced or metastatic NSCLC patients in China
{{output}}
Aim: This retrospective study aimed to assess the efficacy and safety of ensartinib in Chinese patients with ALK-positive advanced NSCLC in real-world clinical practice. ... ...
